Patient Reported Outcomes with JAKi’s in Rheumatoid & Psoratic Arthritis

Time: 3:05 pm
day: Day One


  • Detailing how PROs are an important clinical endpoint for patients
  • Presenting the results of JAKi therapy in RA across DMARD-IR, bDMARDIR and DMARD-naive RA patients; how they correspond w/ clinical endpoints
  • Detailing how these results are clinically meaningful and help patients feel and function as if they no longer have arthritis